Causal Effects of Gut Microbiota on Age-Related Macular Degeneration: A Mendelian Randomization Study

Deshen Mao1,2, Borui Tao2, Shuyan Sheng2

  • 1Department of Ophthalmology, Anqing Municipal Hospital, Anqing, China.

Abstract

Insights

This study reveals specific gut bacteria linked to age-related macular degeneration (AMD). Certain gut microbiota act as protective factors, while others increase AMD risk, offering potential new biomarkers for prevention and treatment.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Genetics

Background:

  • The gut-retina axis highlights the gut microbiota's role in age-related macular degeneration (AMD).
  • A definitive causal link between gut microbiota and AMD remains to be established.

Purpose of the Study:

  • To investigate the causal relationship between gut microbiota and the occurrence of age-related macular degeneration (AMD).
  • To utilize genome-wide association study (GWAS) data and Mendelian randomization (MR) analysis for exploring gut microbiota-AMD associations.

Main Methods:

  • A two-sample Mendelian randomization (MR) analysis was performed using publicly available GWAS summary statistics.
  • Instrumental variables (SNPs) were selected based on stringent quality control and statistical significance thresholds.
  • Causality was primarily assessed using Inverse Variance Weighted (IVW) analysis, with MR-Egger intercept, Cochran's Q, and leave-one-out analyses for robustness.

Main Results:

  • Specific gut bacterial genera, including Anaerotruncus, Candidatus Soleaferrea, and an unknown id.2071, demonstrated a protective effect against AMD.
  • The Eubacterium oxidoreducens group, Faecalibacterium, and Ruminococcaceae UCG-011 were identified as risk factors for AMD.
  • No causal relationships were found at higher taxonomic levels (phylum to family), and bidirectional analysis indicated interactions between certain bacteria and AMD.

Conclusions:

  • Confirmed causal links between specific gut microbiota taxa (Eubacterium oxidoreducens group, Faecalibacterium, Ruminococcaceae UCG-011, Anaerotruncus, Candidatus Soleaferrea) and AMD.
  • These identified gut bacteria present potential as novel biomarkers for AMD.
  • Findings offer insights for developing new strategies for AMD prevention and treatment.